| Patients enrolled (n = 218) |
---|---|
Anthropometric variables | |
 Sex, male/female | 143/75 |
 Age, years | 66.32 ± 10.10 |
 Body mass index, kg/m2 | 24.59 ± 3.46 |
 Waist circumference, cm | 90.19 ± 10.04 |
Laboratory variables | |
 Systolic blood pressure, mmHg | 130.0 (120.0–150.0) |
 Diastolic blood pressure, mmHg | 80.0 (70.0–84.2) |
 Fasting plasma glucose, mmol/L | 5.44 (5.00–6.20) |
 2-h postprandial glucose, mmol/L | 8.58 (6.56–11.50) |
 HbA1c, % | 6.2 (5.7–6.7) |
 HOMA-IR | 4.00 (2.89–6.06) |
 Total cholesterol, mmol/L | 4.42 ± 1.11 |
 Triglyceride, mmol/L | 1.51 (1.07–2.15) |
 HDL-c, mmol/L | 1.11 ± 0.30 |
 LDL-c, mmol/L | 3.01 ± 0.97 |
 C-reactive protein, mg/L | 1.32 (0.57–3.82) |
 FGF21, pg/mL | 300.8 (199.1–407.0) |
 NT-pro-BNP, ng/L | 117.9 (52.6–309.2) |
Ultrasonographic variables | |
 LA dimension, mm | 37.9 ± 5.5 |
 LV mass index, g/m2 | 85.5 (74.6–98.1) |
 LVEF, % | 62.0 (59.0–66.0) |
 LVDd, mm | 46.0 (44.0–49.0) |
 LVSd, mm | 30.8 (28.6–32.9) |
 FS, % | 33.0 (31.0–36.0) |
 IVST, mm | 10.0 (9.0–11.0) |
 PWT, mm | 9.0 (8.0–9.0) |
History | |
 Smoking, n (%) | 99 (45.4) |
 Diabetes, n (%) | 88 (40.4) |
 Hypertension, n (%) | 167 (76.6) |
 Dyslipidemia, n (%) | 196 (89.9) |
 History of CVD, n (%) | 93 (42.7) |